Back to results
TerminatedPhase 1

A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

NCT02008851

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Chicago Medicine

Chicago, Illinois, United States

+4 additional locations

View on ClinicalTrials.gov